Paragh György

Csiha, S., Hernyák, M., Molnár, Á., Lőrincz, H., Katkó, M., Paragh, G., Bodor, M., Harangi, M., Sztanek, F., Berta, E.: Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy.
Biomedicines. 13 (2), 1-16, (article identifier: 438), 2025.

Martos, R., Harangi, M., Szabó, J., Földvári, A., Sándor, J., Katona, É., Tar, I., Paragh, G., Kiss, C., Márton, I.: Effects of Combined Periodontal, Endodontic, and Dentoalveolar Surgical Treatments on Laboratory Parameters in Patients with Hyperlipidemia: A Clinical Interventional Study.
J Clin Med. 14 (1), 1-16, (article identifier: 241), 2025.

Elshorbagy, A., Vallejo-Vaz, A. J., Barkas, F., Lyon, A., Stevens, C. A. T., Dharmayat, K. I., Catapano, A. L., Freiberger, T., Hovingh, G. K., Mata, P., Raal, F. J., Santos, R. D., Soran, H., Watts, G. F., Abifadel, M., Aguilar-Salinas, C. A., Alhabib, K. F., Al-khnifsawi, M., Almahmeed, W., Alnouri, F., Alonso, R., Al-Rasadi, K., Al-Sarraf, A., Arca, M., Ashavaid, T. F., Averna, M., Banach, M., Becker, M., Binder, C. J., Bourbon, M., Brunham, L. R., Chlebus, K., Corral, P., Cruz, D., Davletov, K., Descamps, O., Dwiputra, B., Ezhov, M. V., Groselj, U., Harada-Shiba, M., Holven, K. B., Humphries, S. E., Kayikcioglu, M., Khovidhunkit, W., Lalic, K., Latkovskis, G., Laufs, U., Liberopoulos, E., Lima-Martinez, M. M., Maher, V., Marais, A. D., März, W., Mirrakhimov, E., Miserez, A. R., Mitchenko, O., Nawawi, H., Nordestgaard, B. G., Panayiotou, A. G., Paragh, G., Petrulioniene, Z., Pojskic, B., Postadzhiyan, A., Reda, A., Reiner, Ž., Reyes, X., Sadiq, F., Sadoh, W. E., Schunkert, H., Shek, A. B., Stroes, E., Su, T. C., Subramaniam, T., Susekov, A., Tilney, M., Tomlinson, B., Truong, T. H., Tselepis, A. D., Tybjærg, H. A., Vázquez, C. A., Viigimaa, M., Vohnout, B., Yamashita, S., Ray, K. K., EAS Familial Hypercholesterolaemia Studies Collaboration: Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.
Eur. Heart J. 1, 1-14, 2025.

Tóth, L., Harsányi, A., Csiha, S., Molnár, Á., Lőrincz, H., Nagy, A. C., Paragh, G., Harangi, M., Sztanek, F.: Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: insights from a One-Year Follow-Up Study.
Int. J. Mol. Sci. 26 (13), 1-18, (article identifier: 5951), 2025.

Sztanek, F., Pető, A., Tóth, L., Lőrincz, H., Molnár, Á., Lukács, M., Menyhárt, A., Kempler, P., Paragh, G., Harangi, M., Nagy, A. C.: Sex Differences in Cardiovascular Risk and Diabetic Polyneuropathy: a Single-Center Retrospective Study in North-Eastern Hungary.
J Clin Med. 14 (16), 1-16, (article identifier: 5780), 2025.

Banach, M., Reiner, Ž., Surma, S., Bajraktari, G., Bielecka-Dabrowa, A., Bunc, M., Bytyci, I., Ceska, R., Cicero, A. F. G., Dudek, D., Dyrbus, K., Fedacko, J., Fras, Z., Gaita, D., Gavish, D., Gierlotka, M., Gil, R., Gouni-Berthold, I., Jankowski, P., Járai, Z., Józwiak, J., Katsiki, N., Latkovskis, G., Magda, S. L., Margetic, E., Margoczy, R., Mitchenko, O., Durak-Nalbantic, A., Ostadal, P., Paragh, G., Petrulioniene, Z., Paneni, F., Pećin, I., Pella, D., Postadzhiyan, A., Stoian, A. P., Trbusic, M., Udroiu, C. A., Viigimaa, M., Vinereanu, D., Vlachopoulos, C., Vrablík, M., Vulic, D., Penson, P. E., International Lipid Expert Panel (ILEP): 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: a Position Paper of the International Lipid Expert Panel (ILEP).
Drugs. 84 (12), 1541-1577, 2024.

Nagy, G. G., Márk, L., Gerencsér, A., Reiber, I., Kiss, N., Rokszin, G., Fábián, I., Csanádi, Z., Karádi, I., Aradi, D., Bajnok, L., Paragh, G.: A Nation-Wide Evaluation of Suboptimal Lipid-Lowering Treatment Patterns Among Patients Undergoing Intervention for Acute Coronary Syndrome in Hungary.
J Clin Med. 13 (21), 1-16, (article identifier: 6562), 2024.

European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration: Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.
The Lancet Diabetes & Endocrinology. 12 (11), 811-823, 2024.

Lőrincz, H., Csiha, S., Ratku, B., Somodi, S., Sztanek, F., Paragh, G., Harangi, M.: Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity.
Int. J. Mol. Sci. 25 (11), 1-12, (article identifier: 6264), 2024.

Pető, A., Tóth, L. I., Hernyák, M., Lőrincz, H., Molnár, Á., Nagy, A. C., Lukács, M., Kempler, P., Paragh, G., Harangi, M., Sztanek, F.: Correlations between distal sensorimotor polyneuropathy and cardiovascular complications in diabetic patients in the North-Eastern region of Hungary.
Plos One. 19 (7), 1-13, (article identifier: 0306482), 2024.

Esze, R., Barna, S., Fülöp, P., Kempler, P., Mikó, M., Páll, D., Paragh, G., Somodi, S., Emri, M., Képes, Z., Garai, I., Káplár, M.: C-peptide: an essential ally in microvascular complications of type 2 diabetes mellitus and obesity.
Diabetol Metab Syndr. 16 (1), 2024.

Horváth, J., Seres, I., Paragh, G., Fülöp, P., Jenei, Z.: Effect of Low- and Moderate-Intensity Aerobic Training on Body Composition Cardiorespiratory Functions, Biochemical Risk Factors and Adipokines in Morbid Obesity.
Nutrients. 16 (23), 1-12, (article identifier: 4251), 2024.

Esze, R., Balkay, L., Barna, S., Egeresi, L., Emri, M., Páll, D., Paragh, G., Rajnai, L., Somodi, S., Képes, Z., Garai, I., Káplár, M.: Impact of Fat Distribution and Metabolic Diseases on Cerebral Microcirculation: a Multimodal Study on Type 2 Diabetic and Obese Patients.
J Clin Med. 13 (10), 1-14, (article identifier: 2099), 2024.

Hernyák, M., Tóth, L., Csiha, S., Molnár, Á., Lőrincz, H., Paragh, G., Harangi, M., Sztanek, F.: Kallistatin as a Potential Marker of Therapeutic Response During Alpha-Lipoic Acid Treatment in Diabetic Patients with Sensorimotor Polyneuropathy.
Int. J. Mol. Sci. 25 (24), 1-14, (article identifier: 13276), 2024.

Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, (article identifier: 565), 2024.